News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

Canada study of Merck's COVID-19 oral treatment is moving more slowly - health minister

01/17/2022 | 02:13pm EDT

OTTAWA, Jan 17 (Reuters) - Canada's study into whether to approve Merck & Co Inc's COVID-19 oral antiviral treatment "is moving more slowly", federal Health Minister Jean-Yves Duclos said on Monday.

"There are some specific issues for this medication," Duclos told reporters after Ottawa approved an oral antiviral treatment by Pfizer Inc, but did not give details. In its pivotal clinical trial, Merck's pill had less impressive results than the one produced by Pfizer. (Reporting by David Ljunggren)


© Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
ON SEMICONDUCTOR CORPORATION -2.49% 54.5 Delayed Quote.-19.76%
PFIZER, INC. 1.00% 53.41 Delayed Quote.-9.55%
Latest news "Economy & Forex"
03:20aSouth Africa's Tiger Brands profit drops on volume dip, prolonged strike
RE
03:19aBritain's Pets At Home wins market share as owners pamper furry friends
RE
03:18aEgypt wants to shift focus to developing countries in climate talks -official
RE
03:18aSwiss shoppers to decide if Migros stores end founder's alcohol ban
RE
03:18aSri Lanka's prime minister takes on crucial finance ministry portfolio
RE
03:15aJapan picks five firms to lead sale of Tokyo Metro shares
RE
03:13aAustralia shares rise; New Zealand falls as cenbank hikes rate
RE
03:12aChina clears way for Brazilian corn imports to fill Ukraine gap
RE
03:10aGold prices drop on dollar strength; Fed's minutes in focus
RE
03:09aN.Korea fires salvo of missiles, including ICBM, hours after Biden leaves Asia
RE
Latest news "Economy & Forex"